Fortress Biotech
FBIO
#9206
Rank
NZ$0.18 B
Marketcap
NZ$5.96
Share price
-6.45%
Change (1 day)
82.16%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2025 (TTM): -NZ$93.47 Million

According to Fortress Biotech 's latest financial reports the company's current earnings are NZ$62.3 Million. In 2024 the company made an earning of -NZ$0.21 Billion, an increase over its 2023 earnings that were of -NZ$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$93.47 Million-54.72%
2024 -NZ$0.21 Billion-21.6%
2023 -NZ$0.27 Billion-28.03%
2022 -NZ$0.37 Billion29.88%
2021 -NZ$0.29 Billion59.8%
2020 -NZ$0.18 Billion1.17%
2019 -NZ$0.18 Billion-19.84%
2018 -NZ$0.22 Billion28.99%
2017 -NZ$0.17 Billion37.92%
2016 -NZ$0.13 Billion32.31%
2015 -NZ$92.34 Million164.31%
2014 -NZ$34.94 Million-45.14%
2013 -NZ$63.68 Million37.55%
2012 -NZ$46.3 Million-22.91%
2011 -NZ$60.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS.defunct
-NZ$58.31 Million-36.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
NZ$42.4 M-146.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion 120.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-NZ$58.08 Million-36.62%๐Ÿ‡บ๐Ÿ‡ธ USA